Servier Research Institute

Servier is a global independent pharmaceutical company governed by a non-profit foundation, headquartered in France. The company focuses on five main therapeutic areas: oncology, cardiovascular and metabolic diseases, immune-inflammatory diseases, and neurosciences. Servier invests significantly in R&D, with a major research hub at Paris-Saclay and a growing presence in the United States through Servier Pharmaceuticals. Its portfolio includes both established primary care treatments and innovative precision medicines in oncology, such as IDH inhibitors. The company operates with a unique governance model that allows for long-term reinvestment of profits into research and development. This independence enables Servier to pursue high-risk, high-reward scientific endeavors across diverse modalities including small molecules and cell therapies.